Your browser is no longer supported. Please, upgrade your browser.
TPTX Turning Point Therapeutics, Inc. daily Stock Chart
TPTX [NASD]
Turning Point Therapeutics, Inc.
Index- P/E- EPS (ttm)-3.49 Insider Own2.40% Shs Outstand35.92M Perf Week0.29%
Market Cap2.61B Forward P/E- EPS next Y-4.62 Insider Trans-24.85% Shs Float25.80M Perf Month1.27%
Income-119.30M PEG- EPS next Q-0.89 Inst Own76.60% Short Float11.08% Perf Quarter21.44%
Sales- P/S- EPS this Y-257.70% Inst Trans1.11% Short Ratio7.46 Perf Half Y17.02%
Book/sh10.63 P/B5.84 EPS next Y-1.20% ROA-31.60% Target Price79.63 Perf Year47.83%
Cash/sh9.04 P/C6.86 EPS next 5Y- ROE-32.80% 52W Range31.30 - 72.03 Perf YTD-0.42%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-13.88% Beta-
Dividend %- Quick Ratio34.90 Sales past 5Y- Gross Margin- 52W Low98.15% ATR3.82
Employees102 Current Ratio34.90 Sales Q/Q- Oper. Margin- RSI (14)48.43 Volatility5.87% 5.94%
OptionableYes Debt/Eq0.00 EPS Q/Q-270.00% Profit Margin- Rel Volume0.78 Prev Close59.94
ShortableYes LT Debt/Eq0.00 EarningsMay 12 AMC Payout- Avg Volume383.20K Price62.03
Recom1.50 SMA20-3.38% SMA500.02% SMA20017.25% Volume300,531 Change3.49%
Jul-10-20Initiated Oppenheimer Outperform $90
May-26-20Reiterated H.C. Wainwright Buy $72 → $88
Mar-17-20Reiterated H.C. Wainwright Buy $70 → $72
Nov-14-19Initiated ROTH Capital Buy $65
Sep-25-19Initiated H.C. Wainwright Buy $70
Sep-10-19Initiated Wedbush Outperform
Jul-24-19Initiated Guggenheim Buy $58
May-13-19Initiated Wells Fargo Outperform
May-13-19Initiated SVB Leerink Outperform $42
May-13-19Initiated RBC Capital Mkts Outperform $48
May-13-19Initiated Goldman Buy $50
Jul-13-20 09:00AM  
Jul-07-20 02:50PM  
07:30AM  
Jun-22-20 09:00AM  
Jun-01-20 09:00AM  
May-29-20 08:10AM  
May-28-20 09:13AM  
May-27-20 08:30AM  
May-18-20 08:52PM  
07:00AM  
May-12-20 08:30PM  
04:45PM  
May-11-20 10:57AM  
May-04-20 09:00AM  
Apr-16-20 09:00AM  
Apr-09-20 11:40AM  
Apr-08-20 07:33PM  
10:34AM  
Mar-24-20 08:56AM  
Mar-18-20 02:30PM  
Mar-16-20 09:00AM  
Mar-02-20 08:00AM  
Feb-20-20 09:00AM  
Feb-18-20 09:00AM  
Feb-03-20 09:00AM  
Jan-23-20 09:00AM  
Jan-13-20 09:00AM  
Jan-10-20 07:13AM  
Jan-09-20 05:00PM  
10:01AM  
Jan-06-20 09:00AM  
Dec-27-19 09:17AM  
Dec-26-19 09:53AM  
Dec-23-19 02:30PM  
Dec-17-19 09:00AM  
Dec-10-19 08:33AM  
Nov-19-19 07:24AM  
Nov-13-19 08:30AM  
Nov-12-19 08:30AM  
Nov-11-19 08:30AM  
Nov-08-19 10:34AM  
Nov-07-19 08:18AM  
Nov-04-19 04:05PM  
Oct-28-19 08:03PM  
Oct-21-19 06:00AM  
Sep-30-19 08:30AM  
Sep-18-19 10:15AM  
Sep-11-19 07:15PM  
Sep-09-19 01:57PM  
Sep-05-19 08:34PM  
Sep-03-19 04:14PM  
04:01PM  
Aug-29-19 09:16PM  
Aug-28-19 09:00AM  
Aug-06-19 04:05PM  
Aug-01-19 02:31PM  
Jul-31-19 04:30PM  
08:30AM  
Jul-29-19 08:30AM  
Jul-25-19 08:30AM  
Jul-22-19 09:00AM  
Jun-20-19 09:00AM  
Jun-18-19 07:09AM  
Jun-04-19 08:30AM  
May-31-19 08:30AM  
May-24-19 09:36AM  
May-15-19 09:00AM  
May-14-19 04:30PM  
09:00AM  
May-06-19 09:00AM  
Apr-29-19 12:57PM  
Apr-24-19 08:15PM  
Apr-22-19 04:05PM  
Apr-17-19 11:01AM  
Apr-16-19 10:57PM  
Apr-14-19 09:53AM  
Turning Point Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in designing and developing novel small molecule targeted oncology therapies. It develops a pipeline of tyrosine kinase inhibitors (TKIs) that targets genetic drivers of cancer in TKI-naive and TKI-pretreated patients. The company's lead drug candidate repotrectinib is being evaluated in an ongoing Phase I/II trial called TRIDENT-1 for the treatment of patients with ROS1+ advanced non-small-cell lung cancer (NSCLC) and patients with ROS1+, NTRK+, or ALK+ advanced solid tumors. Its pipeline also includes multi-targeted drug candidates TPX-0046, a RET/SRC inhibitor; TPX-0022, a MET/CSF1R/SRC inhibitor; and TPX-0131, a preclinical ALK inhibitor. The company was founded in 2013 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cui Jingrong JeanDirectorJun 09Sale65.819,500625,194540,383Jun 10 05:26 PM
Cui Jingrong JeanDirectorJun 08Sale63.4518,5001,173,888549,883Jun 08 08:26 PM
Cui Jingrong JeanDirectorJun 05Sale64.2118,5001,187,868568,383Jun 08 08:26 PM
Cui Jingrong JeanDirectorJun 04Sale64.8018,5001,198,891586,883Jun 08 08:26 PM
GLAXOSMITHKLINE PLCDirectorMay 21Buy60.0083,3334,999,9802,253,660May 26 04:17 PM
George SimeonDirectorMay 21Buy60.0083,3334,999,9802,253,660May 26 05:57 PM
Countouriotis AthenaPresident & CEOMay 21Buy60.004,166249,96026,872May 26 05:55 PM
Cui Jingrong JeanDirectorMay 21Sale59.657,000417,550605,383May 21 07:05 PM
Cui Jingrong JeanDirectorMay 20Sale60.157,000421,045612,383May 21 07:05 PM
Cui Jingrong JeanDirectorMay 19Sale57.737,000404,108619,383May 21 07:05 PM
Cui Jingrong JeanDirectorMay 08Sale53.8611,500619,351626,383May 12 08:09 PM
Cui Jingrong JeanDirectorMay 07Sale52.8618,500977,886637,883May 07 06:52 PM
Cui Jingrong JeanDirectorMay 06Sale52.9418,500979,323656,383May 07 06:52 PM
Cui Jingrong JeanDirectorMay 05Sale54.0218,500999,426674,883May 07 06:52 PM
Cui Jingrong JeanDirectorApr 24Sale51.017,000357,090693,383Apr 24 08:20 PM
Cui Jingrong JeanDirectorApr 23Sale51.927,000363,408700,383Apr 24 08:20 PM
Cui Jingrong JeanDirectorApr 22Sale51.787,000362,481707,383Apr 24 08:20 PM
Cui Jingrong JeanDirectorApr 13Sale50.0570835,438714,383Apr 13 07:16 PM
Cui Jingrong JeanDirectorApr 09Sale47.4511,500545,648715,091Apr 13 07:16 PM
Cui Jingrong JeanDirectorApr 08Sale46.2518,500855,604726,591Apr 08 07:21 PM
Cui Jingrong JeanDirectorApr 07Sale44.8618,500829,998745,091Apr 08 07:21 PM
Cui Jingrong JeanDirectorApr 06Sale43.5118,500804,874763,591Apr 08 07:21 PM
Cui Jingrong JeanDirectorMar 26Sale46.0311,500529,372782,091Mar 27 06:27 PM
Cui Jingrong JeanDirectorMar 25Sale45.4217,792808,090793,591Mar 25 06:47 PM
Cui Jingrong JeanDirectorMar 24Sale41.957,000293,655811,383Mar 25 06:47 PM
Cui Jingrong JeanDirectorMar 23Sale38.397,000268,706818,383Mar 25 06:47 PM
Cui Jingrong JeanDirectorMar 12Sale36.087,000252,528825,383Mar 12 08:40 PM
Cui Jingrong JeanDirectorMar 11Sale41.2018,500762,202832,383Mar 12 08:40 PM
Cui Jingrong JeanDirectorMar 10Sale42.2818,500782,113850,883Mar 12 08:40 PM
Cui Jingrong JeanDirectorFeb 26Sale51.437,000360,014869,383Feb 26 08:20 PM
Cui Jingrong JeanDirectorFeb 25Sale51.357,000359,478876,383Feb 26 08:20 PM
Cui Jingrong JeanDirectorFeb 24Sale53.707,000375,930883,383Feb 26 08:20 PM
Cui Jingrong JeanDirectorFeb 13Sale61.8411,500711,137781,219Feb 14 04:22 PM
Cui Jingrong JeanDirectorFeb 12Sale65.9218,5001,219,594792,719Feb 12 07:31 PM
Cui Jingrong JeanDirectorFeb 11Sale63.2318,5001,169,668811,219Feb 12 07:31 PM
Cui Jingrong JeanDirectorFeb 10Sale62.9418,5001,164,482829,719Feb 12 07:31 PM
Cui Jingrong JeanChief Scientific OfficerJan 29Sale58.737,000411,104848,219Jan 29 07:37 PM
Cui Jingrong JeanChief Scientific OfficerJan 28Sale58.367,000408,529855,219Jan 29 07:37 PM
Cui Jingrong JeanChief Scientific OfficerJan 27Sale57.667,000403,652862,219Jan 29 07:37 PM
Cui Jingrong JeanChief Scientific OfficerJan 15Sale53.1211,500610,853869,219Jan 17 05:10 PM
Cui Jingrong JeanChief Scientific OfficerJan 14Sale53.5618,500990,811880,719Jan 14 07:17 PM
Cui Jingrong JeanChief Scientific OfficerJan 13Sale52.8718,500978,073899,219Jan 14 07:17 PM
Cui Jingrong JeanChief Scientific OfficerJan 10Sale57.6818,5001,067,161917,719Jan 14 07:17 PM
Cui Jingrong JeanDirectorDec 30Option Exercise5.1216,86486,344890,383Feb 26 08:18 PM
Cui Jingrong JeanDirectorDec 27Option Exercise4.7138,080179,456873,519Feb 26 08:18 PM
Cui Jingrong JeanChief Scientific OfficerDec 20Sale63.4011,500729,150936,219Dec 20 06:29 PM
Cui Jingrong JeanChief Scientific OfficerDec 19Sale61.0918,5001,130,257947,719Dec 20 06:29 PM
Cui Jingrong JeanChief Scientific OfficerDec 18Sale59.2018,5001,095,170966,219Dec 20 06:29 PM
Cui Jingrong JeanChief Scientific OfficerDec 17Sale61.3218,5001,134,374984,719Dec 17 09:09 PM
Cui Jingrong JeanChief Scientific OfficerDec 16Sale58.3511,500671,0771,003,219Dec 17 09:09 PM
Cui Jingrong JeanChief Scientific OfficerDec 13Sale55.7511,500641,1691,014,719Dec 17 09:09 PM
Cui Jingrong JeanChief Scientific OfficerDec 12Sale54.1111,500622,2911,026,219Dec 12 07:54 PM
Cui Jingrong JeanChief Scientific OfficerDec 11Sale52.9411,500608,7871,037,719Dec 12 07:54 PM
Cui Jingrong JeanChief Scientific OfficerDec 10Sale54.5811,500627,6311,049,219Dec 12 07:54 PM
Cui Jingrong JeanChief Scientific OfficerDec 09Sale55.3211,500636,2291,060,719Dec 09 08:44 PM
Cui Jingrong JeanChief Scientific OfficerDec 06Sale50.7750,8902,583,5881,072,219Dec 09 08:44 PM
Cui Jingrong JeanChief Scientific OfficerDec 05Sale51.9556,1102,914,9361,123,109Dec 09 08:44 PM